<DOC>
	<DOC>NCT01644422</DOC>
	<brief_summary>This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Androgenetic Alopecia undergoing hair transplantation. The study is being conducted at 2 centers in India. The primary endpoints are Increase in Hair Follicle viability after transplant, Improvement in Caliber &amp; Density of hair and Improvement in Photographic assessment from randomization to end of study. The secondary endpoints are Physicians and Patients self assessment score.</brief_summary>
	<brief_title>Study To Determine Safety &amp; Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Male subjects, aged between 18 to 50 years (both inclusive) and in general good health Subjects willing to refrain from other AGA treatments during the entire study duration Subjects who are willing to give informed consent and adhere to the study protocol Subjects aged &lt;18 or &gt; 50 years Subjects with dermatological disorder of scalp that might interfere with study evaluation Subjects on Anticoagulant therapy Subjects with clinically significant medical or psychiatric disease as determined by the investigator. Subjects unwilling to or unable to comply with the study protocol. Subjects taking concomitant therapy that might interfere with the study results in investigators opinion or participating in another trial in the past 30 days.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>